Allogeneic CD19/BCMA CAR-T cells
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Allogeneic CD19/BCMA CAR-T cells, covering 2025-07-10 to 2025-07-10. Get the full timeline:
Most recent: Clinical Trial Update: A Clinical Study of Allogeneic CD19/BCMA CAR-T Cells for the Treatment of R/R B-cell Malignant Tumors [EARLY_Phase 1]